Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4Gynecologic 4Gastrointestinal 4Breast 4Thoracic 3Lymphoid 3Sarcoma 2Other hematologic neoplasm 2Myeloid 2Genitourinary 2Dermatologic 2CNS 2Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 6Head and Neck Neoplasms 5Vomiting 3Nasopharyngeal Carcinoma 3Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Salivary Gland Adenoma, Pleomorphic 1Rectal Neoplasms 1Prostatic Neoplasms 1Pain, Postoperative 1Pain 1Neoplasms, Unknown Primary 1Neoplasms, Squamous Cell 1Neoplasms 1Neoplasm Metastasis 1Nausea 1Mouth Neoplasms 1Mesothelioma 1Malnutrition 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Deglutition Disorders 1Breast Neoplasms 1

Interventions

Palonosetron 2fosaprepitant 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Olanzapine 1Electroacupuncture 1Dexamethasone 1Cisplatin 1Calcium Dobesilate 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Dexamethasone × Head & Neck × Clear all
NCT00895245 2017-05-18

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

University of Washington

Phase 2 Terminated
6 enrolled 5 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡